The European Patent Office (EPO) has published patent application EP4709256A1, detailing "AI systems for retinal disease treatment." The publication date is March 18, 2026, and it identifies John Gregory Ladas as both the applicant and inventor. The application includes various International Patent Classifications related to medical diagnostics, artificial intelligence, and image processing.

This publication represents a new patent filing and does not impose any immediate regulatory obligations on regulated entities. However, it signifies ongoing innovation in the intersection of AI and healthcare, specifically in ophthalmology. Companies operating in the medical device and pharmaceutical sectors, particularly those developing AI-driven diagnostic or therapeutic tools for eye conditions, should be aware of this patent application as it may relate to their intellectual property landscape or future product development.